USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
DXDISCOVERY, INC.
Address:
Applied Research Facilty MS 328
RENO, NV 89557-0001
Phone:
(775) 223-6169
URL:
EIN:
146122500
DUNS:
78634704
Number of Employees:
5
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $689,865.00 2
STTR Phase I $1,191,671.00 2

Award List:

Biomarker discovery for immunodiagnosis of invasive candidiasis

Award Year / Program / Phase:
2013 / STTR / Phase I
Award Amount:
$600,000.00
Agency:
HHS
Principal Investigator:
Thomas R. Kozel – 775-784-4124
Research Institution:
UNIVERSITY OF NEVADA
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): Invasive candidiasis (IC) is one of the most serious threats to patients in a critical setting. With as many as 60,000 cases per year in the U.S., the total cost associated with IC in the U.S. may be as high as 2-4 billion/year. One of the most critical factors… More

High-affinity monoclonal antibodies that target Burkholderia Polysaccharide

Award Year / Program / Phase:
2014 / SBIR / Phase I
Award Amount:
$99,999.00
Agency / Branch:
DOD / CBD
Principal Investigator:
Mark Hubbard, Chief Technology Officer – (509) 388-8883
Abstract:
Melioidosis and glanders are life-threatening illnesses caused by the bacteria Burkholderia pseudomallei and Burkholderia mallei, respectively. These gram-negative bacilli are endemic to Northern Australia and Southeast Asia, however endemic regions are expanding as surveillance improves. B.… More

Point-of-care immunoassay for early diagnosis of pertussis

Award Year / Program / Phase:
2014 / SBIR / Phase I
Award Amount:
$589,866.00
Agency:
HHS
Principal Investigator:
Amanda R. Burnham-marus – 541-521-5291
Abstract:
DESCRIPTION (provided by applicant): Pertussis is a serious and potentially life-threatening respiratory disease caused by the bacterium Bordetella pertussis. Worldwide, 18.4 million people become ill with pertussis each year, and 254,000 of these patientsdie. Despite high vaccine coverage in the… More

Identification of Borrelia burgdorferi diagnostic biomarkers in humans and nonhum

Award Year / Program / Phase:
2014 / STTR / Phase I
Award Amount:
$591,671.00
Agency:
HHS
Principal Investigator:
David P. Aucoin – 775-784-4090
Research Institution:
TULANE UNIVERSITY OF LOUISIANA
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): The number of Lyme disease cases in the US has been recently estimated by the CDC at 300,000 cases/year. This is major public health concern. Currently available diagnostics rely on detection of the antibody response (serology) to Borrelia burgdorferi, the… More